Juvenile Idiopathic Arthritis Clinical Trial
— ATHLETIQUEOfficial title:
Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study
NCT number | NCT05572424 |
Other study ID # | 2021/600 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 5, 2023 |
Est. completion date | October 2024 |
The Juvenile Idiopathic Arthritis (JIA) affects joints mobility and leads pain, impacting the practice of physical activities. Adapted Physical Activities are rehabilitation methods increasingly used, but additional studies are needed to define the nature of the physical activity for patients with JIA. The ATHLETIQUE project aims to evaluate the impact of a program integrating APA sessions together with the wearing of a pedometer watch on disease activity of patients with JIA.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | October 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 17 Years |
Eligibility | Inclusion criteria: - Children (boys and girls) aged 6 to 17 years - Children with juvenile idiopathic arthritis (JIA) : oligoarticular, polyarticular, psoriatic or enthesitis-related arthritis, with more than one year of disease progression - Children on stable conventional or biotherapy 3 months prior to inclusion - Children with a computer/tablet/connected phone that allows them to follow adapted physical activities sessions online - If sexually active adolescents, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double barrier method, contraceptive patches) - Signed informed consent to participate indicating that the parent(s) understand the purpose and procedures required for the study and agree(s) that their child(ren) will participate in the study and abide by the requirements and restrictions of the study - Affiliation with a French social security system or beneficiary of such a system. Non-inclusion criteria: - Treatment by intra-articular infiltration less than 1 month old (immobilization required after the procedure and temporary cessation of physical activity unavoidable) - Contraindications to physical activity - Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator - Subject without health insurance - Pregnant adolescent - Subject in the exclusion period of another study or is the "national volunteer register" Exclusion criteria : - Intra-articular infiltration treatment during the 3 months of the adapted physical activity (APA) program (except for the temporomandibular joint) - Change of biotherapy during the 3 months of the APA program if the treatment is ineffective - Physical inability to engage in physical activity, unrelated to JIA, during the 3-month of the APA program |
Country | Name | City | State |
---|---|---|---|
France | CHU de Besançon | Besançon | |
France | Hospices Civils de Lyon | Lyon | |
France | Hôpital Nord Franche-Comté | Trévenans |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Besancon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Juvenile Arthritis Disease Activity-27 Score Assesment | JADAS-27 score includes 4 components :
number of inflammatory joints among 27 joints identified, a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best), assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best), sedimentation rate (from 0 to 10). |
Week 14 | |
Secondary | Juvenile Arthritis Disease Activity-27 Score Assesment | JADAS-27 score includes 4 components :
number of inflammatory joints among 27 joints identified, a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best), assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best), sedimentation rate (from 0 to 10). |
Weeks 26 and 50 | |
Secondary | Evaluation of the physical activity level | The difference of the medium physical activity level is assessed by the continue measures (for 7 days) of the time spent in the MVPA (Moderate to Vigorous Physical Activity) via actimetry (counts/min).
Actimetric measurements will be performed before the start of the intervention to determine a value for V0, at 13 weeks (for V1), at 25 weeks (for V2), and at 49 weeks (for V3) |
Weeks 13, 25 and 49 | |
Secondary | Evaluation of the physical activity level | The difference of the medium physical activity level is assessed by the number of steps estimated by the pedometer watch (only for the experimental group).
Pedometric measurements will be performed throughout the study but collected one week per month to determine a monthly value. |
Each day during 50 weeks | |
Secondary | Quantification of the difference in muscle strength | By dynamometry (Newton) | Weeks 14, 26 and 50 | |
Secondary | Evolution of quality of life | Difference of the score obtained in the Pediatric Quality of Life (PedsQL) tool. Score out of 100 for children assess and 100 for parents assess. A high score means a reduced quality of life. | Weeks 14, 26 and 50 | |
Secondary | Evolution of functional capacities | Assessment by the questionnaire of the ChildHood Assessment Questionnaire (CHAQ-38) tool. Questionaire's score out of 3, it's a medium of 8 items. A high score means reduced functional capacities. | Weeks 14, 26 and 50 | |
Secondary | Evolution of pain | Assessment by the Visual Analogic Scale (VAS) of the CHAQ-38 tool. VAS are out of 10. A high score means an increased pain. | Weeks 14, 26 and 50 | |
Secondary | Evolution of fatigue | Difference of the score obtained in the PedsQL-Multidimensional Fatigue Scale questionnaire. Score out of 100 for children assess and 100 for parents assess. A high score means a increased fatigue. | Weeks 14, 26 and 50 | |
Secondary | Assessment of the feasibility of the program | Assessment of program participation. Participation is the proportion of subjects who agree to participate in the study among eligible patients. | week 2 to 13 | |
Secondary | Assessment of the feasibility of the program | Assessment of program completion. Completion is the proportion of subjects who complete the program and proportion of subjects who complete the exercise sessions. | week 2 to 13 | |
Secondary | Assessment of the feasibility of the program | Assessment of program adherence. Adherence is the proportion of sessions attended by subjects. | week 2 to 13 | |
Secondary | Assessment of the feasibility of the program | Assessment of program compliance. Compliance is the proportion of prescribed exercise during the session actually performed. | week 2 to 13 | |
Secondary | Assessment of the feasibility of the program | Assessment of pedometer watch wearing time over the duration of the study. | week 1 to 50 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02776735 -
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
|
Phase 2 | |
Active, not recruiting |
NCT03092427 -
Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)
|
N/A | |
Not yet recruiting |
NCT05545098 -
MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
|
||
Not yet recruiting |
NCT03833609 -
Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis
|
N/A | |
Completed |
NCT02524340 -
Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
|
||
Recruiting |
NCT01434082 -
Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
|
N/A | |
Completed |
NCT04671524 -
The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected
|
N/A | |
Recruiting |
NCT04167488 -
Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy
|
N/A | |
Recruiting |
NCT04205500 -
Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis
|
N/A | |
Terminated |
NCT01694264 -
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
|
Phase 3 | |
Completed |
NCT02824978 -
Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
|
||
Active, not recruiting |
NCT03841357 -
Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
|
Phase 3 | |
Completed |
NCT03833271 -
The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary
|
Early Phase 1 | |
Completed |
NCT01455701 -
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
|
Phase 1 | |
Completed |
NCT05031104 -
Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis
|
N/A | |
Not yet recruiting |
NCT01436019 -
Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
|
N/A | |
Recruiting |
NCT05609630 -
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
|
Phase 3 | |
Recruiting |
NCT05696340 -
Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
|
||
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Completed |
NCT05436301 -
Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)
|